by In2Pharma | Jan 20, 2026 | News
Belgium The FAMHP has updated the web portal ‘Co-responsibility’ on 14 January 2026. The main goal of this update is to enhance safety, harmonize GMP and GDP processes, and improve the traceability of inspection document archiving. The most important changes are: The...
by In2Pharma | Nov 19, 2025 | News
Belgium Following the award of a new public contract, BNP Paribas Fortis will take over the federal government’s public bank accounts from bpost during the weekend of 13 and14 December 2025. The FAMHP, in close collaboration with the FPS Finance (project coordinator),...
by In2Pharma | May 22, 2025 | News
Belgium In 2023, a new royal decree (19 January 2023) was issued by the Belgian government allowing the export (every shipment to another country) of medicines to be temporarily restricted. The importance of complying with the decree has been made very clear as this...
by In2Pharma | May 22, 2025 | News
Belgium The FAMHP launched a new version of Narcoreg, the mandatory online application for the registration of deliveries and receipts of narcotics and psychotropic substances, on 21 May 2025. The new version was developed based on valuable feedback from the industry...
by In2Pharma | Jan 8, 2025 | News
Belgium Companies with a GDP-certificate with validity date end December 2024, should have received – addressed to their RP – a communication from the FAMHP with regard to the GDP-certificate expiring in December 2024. In parallel, the below...
